Skin Necrosis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 309 Experts worldwide ranked by ideXlab platform

S.s. Wynn - One of the best experts on this subject based on the ideXlab platform.

David Lillicrap - One of the best experts on this subject based on the ideXlab platform.

  • multicentric warfarin induced Skin Necrosis complicating heparin induced thrombocytopenia
    American Journal of Hematology, 1999
    Co-Authors: Theodore E Warkentin, William M Sikov, David Lillicrap
    Abstract:

    Two patients developed catastrophic multicentric Skin Necrosis while receiving warfarin to treat venous thromboembolism complicated by immune-mediated heparin-induced thrombocytopenia (HIT). Patient 1 developed Skin Necrosis involving the breasts, thighs, and face, as well as venous limb gangrene and bilateral hemorrhagic Necrosis of the adrenal glands, resulting in death. The second patient developed bilateral mammary Necrosis necessitating mastectomies, as well as Skin Necrosis involving the thigh. Neither patient had an identifiable hypercoagulable syndrome, other than HIT. HIT may represent a risk factor for the development of multicentric warfarin-induced Skin Necrosis (WISN).

  • Multicentric warfarin‐induced Skin Necrosis complicating heparin‐induced thrombocytopenia
    American Journal of Hematology, 1999
    Co-Authors: Theodore E Warkentin, William M Sikov, David Lillicrap
    Abstract:

    Two patients developed catastrophic multicentric Skin Necrosis while receiving warfarin to treat venous thromboembolism complicated by immune-mediated heparin-induced thrombocytopenia (HIT). Patient 1 developed Skin Necrosis involving the breasts, thighs, and face, as well as venous limb gangrene and bilateral hemorrhagic Necrosis of the adrenal glands, resulting in death. The second patient developed bilateral mammary Necrosis necessitating mastectomies, as well as Skin Necrosis involving the thigh. Neither patient had an identifiable hypercoagulable syndrome, other than HIT. HIT may represent a risk factor for the development of multicentric warfarin-induced Skin Necrosis (WISN).

D.w. Essex - One of the best experts on this subject based on the ideXlab platform.

Gerard Stansby - One of the best experts on this subject based on the ideXlab platform.

  • warfarin induced Skin Necrosis
    British Journal of Surgery, 2000
    Co-Authors: Y C Chan, D Valenti, A O Mansfield, Gerard Stansby
    Abstract:

    ral anticoagulation therapy with warfarin may cause injury to the Skin. Cutaneous injury from warfarin begins as localized paresthesias with an erythematous flush, progresses to petechiae and hemorrhagic bullae, and may eventually result in full-thickness Skin Necrosis. Patients typically experience pain in affected areas. The onset of disease is usually between the third and sixth day of therapy. Early recognition and treatment are important to avoid substantial morbidity. This article describes the clinical course of a patient who developed warfarin-induced Skin Necrosis (WISN) and discusses the clinical manifestations, diagnosis, treatment, and prevention of this condition.

Lyn M Duncan - One of the best experts on this subject based on the ideXlab platform.

  • warfarin induced Skin Necrosis
    Journal of The American Academy of Dermatology, 2009
    Co-Authors: Rosalynn M Nazarian, Elizabeth M Van Cott, Artur Zembowicz, Lyn M Duncan
    Abstract:

    Warfarin-induced Skin Necrosis is a rare complication of anticoagulant therapy with a high associated morbidity and mortality requiring immediate drug cessation. Cutaneous findings include petechiae that progress to ecchymoses and hemorrhagic bullae. Characteristic dermatopathological findings are diffuse dermal microthrombi with endothelial cell damage and red cell extravasation with progression to full-thickness coagulative Necrosis. The lesions of warfarin-induced Skin Necrosis may be difficult to differentiate from mimickers, but Skin biopsy in conjunction with careful consideration of the clinical history, including time of onset, cutaneous distribution of the lesions, and laboratory findings, are essential for prompt diagnosis and patient treatment. Herein, we review the clinical and histologic features helpful for differentiating warfarin-induced Skin Necrosis and report a case illustrative of the diagnostic difficulty that may at times be encountered in clinical practice.